Showing 1 - 1 results of 1 for search 'Lijun Di', query time: 0.01s Refine Results
  1. 1
    Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study

    Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study by Jiaxuan Liu, Jiayang Zhang, Huiping Li, Guohong Song, Lijun Di, Hanfang Jiang, Ying Yan, Huan Wang, Jing Wang, Xiaoran Liu, Bin Shao, Qiao Li

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: